Home › Sudden Cardiac Arrest › Washington › Seattle
Sudden Cardiac Arrest clinical trials in Seattle, WA
6 studies for Sudden Cardiac Arrest are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Cardiac Arrest - Ultrasound Detection of Occult Perfusion
RecruitingObservational study
- University of Washington, Seattle
Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest
RecruitingObservational study
- Seattle Children's, Seattle
Optimal Ventilation for Cardiac Arrest
Recruiting
- Seattle Children's, Seattle
Quality of Pediatric Resuscitation in a Multicenter Collaborative
RecruitingObservational study
- Seattle Children's Hospital, Seattle
Simulation Trial of Telemedical Support for Paramedics
Recruiting
- University of Washington, Seattle
Effectiveness of Exercise After an ICD
Recruiting
- University of Washington, Seattle
About Sudden Cardiac Arrest
In sudden cardiac arrest (SCA), an irregular heart rhythm causes the heart to stop beating. Without quick treatment, it causes sudden cardiac death. Learn more.
More about Sudden Cardiac Arrest on MedlinePlus
Sudden Cardiac Arrest trials in other cities
- New York City, NY8 studies
- Boston, MA6 studies
- Philadelphia, PA6 studies
- San Francisco, CA4 studies
- Queens, NY4 studies
- Durham, NC4 studies
- Chicago, IL4 studies
- Dallas, TX4 studies
- Richmond, VA4 studies
- Cincinnati, OH4 studies
- Austin, TX3 studies
- St. Louis, MO3 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer55 studies
- Cancer (all types)48 studies
- Prostate Cancer45 studies
- Acute Myeloid Leukemia40 studies
- Metastatic Cancer39 studies
- Breast Cancer37 studies
- Colorectal Cancer35 studies
- Lung Cancer34 studies
- Ovarian Cancer29 studies
- Pancreatic Cancer22 studies
- Multiple Myeloma22 studies
- Acute Lymphoblastic Leukemia22 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.